Recall
FDAHealthFebruary 28, 2025

Glenmark Pharmaceuticals Inc., USA — Carvedilol Tablets USP 3.125mg Tablets a.)100-count bottle (NDC 68462-162-01), b.) 500-count bottle (NDC 68462-162-05), Rx Only, Manufactured by: Glenmark Pharma

⚠️ CGMP Deviations; presence 'N-Nitroso Carvedilol I' Impurity above the recommended acceptable intake limit

Is this relevant to me?

Geography
Nationwide
Source agency
FDA
Category
Health
Published
February 28, 2025

U.S. Nationwide

What's affected?

Product
Carvedilol Tablets USP 3.125mg Tablets a.)100-count bottle (NDC 68462-162-01), b.) 500-count bottle (NDC 68462-162-05), Rx Only, Manufactured by: Glenmark Pharmaceuticals Ltd., Manufactured for: Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ 07430.
UPC
0368462162019
Lot code
19231450

Additional details

[100-Count Bottles] Lot 19231450, Exp Mar-25, 19233345, Exp Jul-25; Lot 19234275, Exp Sep-25; Lot 19240280, Exp DEC-25 [500-Count Bottles] Lot 19231450, 19231464, 19231471, 19231493, Exp Mar-25, 19232083, 19232103 Exp Apr-25, 19232658, Exp Jun-25; Lot 19233328, 19233343, 19233344, 19233345, Exp Jul-25; Lot 19234275, Exp Sep-25; Lots 19234843, 19235039, Exp Nov-25; Lots 19240280, 19240296, Dec-25

What should I do?

Recommended action

Class II recall. Voluntary: Firm initiated Quantity affected: [100 Tablet Bottles] 59,952 bottles; [500 Tablet Bottles] 155,976 bottles.

View original FDA notice →

Get Health recall alerts

Delivered to your inbox. Free. No account required.